Document is current

Article History

Received: 23 August 2024

Accepted: 28 January 2025

First Online: 6 February 2025

Declarations

:

: The Ottawa Health Sciences Network Research Ethics Board deemed this project falls within the context of quality initiative, quality improvement, and program evaluation. Consequently, as per the Tri-Council Policy Statement 2, Article 2.5, the REB determined that the proposal is not ‘human subject research’; therefore, review by the OHSN-REB is not required.The need for consent to participate was waived by the Ottawa Health Sciences Network REB as this was deemed a quality improvement initiative. This study adhered to the Declaration of Helsinki.

: By submitting my article I agree to pay the APC in full if my article is accepted for publication (unless it is covered by an institutional agreement or journal partner, or a full waiver has been granted). If identifying images or other personal or clinical details of participants are presented that compromise anonymity, a statement of consent to publish from the patient should be included. Not applicable.

: Dr. Lochnan held grant by Spruce pharmaceuticals for study on CAH within last 2 years. She provides eConsults through the Ontario eConsult program for which she is compensated. Dr. Keely is the Executive Director of the eConsult Centre of Excellence at the Ottawa Hospital who receives funding from Ontario Health. She is the Clinical Lead, Central Waitlist Management Program at Ontario Health for which she receives a stipend. Dr. Clare Liddy is the Evaluation Lead for the eConsult Centre of Excellence at The Ottawa Hospital, which receives funding from Ontario Health. She also serves as the Digital Clinical Lead at Ontario Health, for which she receives salary support.